Effectiveness of Upadacitinib and Biologics for the Achievement of Minimal Disease Activity in Adults With Moderate-to-Severe Atopic Dermatitis (RAMpUp)

NCT07741838 · clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
900
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

AbbVie